Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Head of OCDEM
-
David Ray
Professor of Endocrinology and Co-Director Sir Jules Thorn Sleep and Circadian Neuroscience Institute
Latest publications
-
Service evaluation suggests variation in clinical care provision in adults with congenital adrenal hyperplasia in the UK and Ireland.
Journal article
Doyle LM. et al, (2024), Clin Endocrinol (Oxf)
-
Genome-wide characterization of circulating metabolic biomarkers.
Journal article
Karjalainen MK. et al, (2024), Nature
-
Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study.
Journal article
Bonaventura I. et al, (2024), J Endocrinol Invest
-
GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells
Journal article
Shilleh AH. et al, (2024), Peptides, 171179 - 171179
Latest News
Professor Rury Holman wins 2024 Banting Medal for Scientific Achievement
6 March 2024
The American Diabetes Association (ADA) has announced this year's National Scientific and Health Care Achievement Award recipients.
Race to cure type 1 diabetes gets a new boost
7 December 2023
RDM group awarded £2.55 million for diabetes research.
Diabetes UK visits OCDEM labs
21 November 2023
OCDEM Vacancies
Events
View previous and upcoming events in OCDEM.